The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors

Modern Pathology

Volumn 25, Issue 4, 2012, Pages 537-547

  Sigstad, Eva ^a   Paus, Elisabeth ^a   Bjøro, Trine ^a,b   Berner, Aasmund ^a,b   Grøholt, Krystyna Kotanska ^a   Jørgensen, Lars H ^a   Sobrinho Simões, Manuel ^c   Holm, Ruth ^a   Warren, David J ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

ARG2; C1orf24; DDIT3; FAM129A; ITM1; STT3A; thyroid carcinoma

Indexed keywords

BIOLOGICAL MARKER; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; POLYCLONAL ANTIBODY; PROTEIN ARGINASE2; PROTEIN FAM129A; PROTEIN STT3A; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; TISSUE MICROARRAY;

ADENOMA; ARGINASE; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; HEXOSYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NORWAY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTOR CHOP; TUMOR MARKERS, BIOLOGICAL;

EID: 84859425237     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.188     Document Type: Article

References (43)

1. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-1771.
2. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993;118: 282-289. (Pubitemid 23046388)
3. Suen KC. Fine-needle aspiration biopsy of the thyroid. CMAJ 2002;167:491-495. (Pubitemid 35034617)
4. Hamberger B, Gharib H, Melton III LJ, et al. Fineneedle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 1982;73: 381-384. (Pubitemid 12031790)
5. Fadda G, Rabitti C, Minimo C, et al. Morphologic and planimetric diagnosis of follicular thyroid lesions on fine needle aspiration cytology. Anal Quant Cytol Histol 1995;17:247-256.
6. Fadda G, Balsamo G, Fiorino MC, et al. Follicular thyroid lesions and risk of malignancy: a new diagnostic classification on fine-needle aspiration cytology. J Exp Clin Cancer Res 1998;17:103-107. (Pubitemid 28215974)
7. Baloch ZW, Fleisher S, Livolsi VA, et al. Diagnosis of 'follicular neoplasm': a gray zone in thyroid fineneedle aspiration cytology. Diagn Cytopathol 2002;26: 41-44. (Pubitemid 34037526)
8. Yang GC, Liebeskind D, Messina AV. Should cytopathologists stop reporting follicular neoplasms on fine-needle aspiration of the thyroid? Cancer 2003;99: 69-74. (Pubitemid 36529727)
9. Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007; 111:306-315.
10. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007;111: 508-516. (Pubitemid 350304903)
11. Schlinkert RT, van Heerden JA, Goellner JR, et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is 'suspicious for follicular neoplasm'. Mayo Clin Proc 1997;72:913-916.
12. Goodell WM, Saboorian MH, Ashfaq R. Fine-needle aspiration diagnosis of the follicular variant of papillary carcinoma. Cancer 1998;84:349-354. (Pubitemid 29031395)
13. Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fineneedle aspiration. Thyroid 1998;8:377-383. (Pubitemid 28252418)
14. Carpi A, Menchini FF, Ferrari E, et al. Aspiration needle biopsy in preoperative selection of thyroid nodules defined at fine-needle aspiration as microfollicular lesions. Am J Clin Oncol 1999;22:65-69. (Pubitemid 30261594)
15. Raber W, Kaserer K, Niederle B, et al. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid 2000;10:709-712.
16. Renshaw AA. Follicular lesions of the thyroid. Am J Clin Pathol 2001;115:782-785.
17. Matesa N, Tabain I, Dabelic N, et al. Diagnostic relevance of fine needle aspiration cytology for follicular lesions of the thyroid: retrospective study. Croat Med J 2002;43:606-609. (Pubitemid 35364509)
18. Stelow EB, Bardales RH, Crary GS, et al. Interobserver variability in thyroid fine-needle aspiration interpretation of lesions showing predominantly colloid and follicular groups. Am J Clin Pathol 2005;124:239-244. (Pubitemid 41060135)
19. Deveci MS, Deveci G, Livolsi VA, et al. Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up. Cytojournal 2006;3:9.
20. Mijovic T, Rochon L, Gologan O, et al. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions. Otolaryngol Head Neck Surg 2009;140:715-719.
21. Layfield LJ, Morton MJ, Cramer HM, et al. Implications of the proposed thyroid fine-needle aspiration category of 'follicular lesion of undetermined significance': A five-year multi-institutional analysis. Diagn Cytopathol 2009;37:710-714.
22. Nayar R, Ivanovic M. The indeterminate thyroid fineneedle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer 2009; 117:195-202.
23. Barden CB, Shister KW, Zhu B, et al. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 2003;9: 1792-1800. (Pubitemid 36554606)
24. Aldred MA, Huang Y, Liyanarachchi S, et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol 2004;22:3531-3539. (Pubitemid 41103659)
25. Finley DJ, Zhu B, Barden CB, et al. Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg 2004;240:425-436.
26. Lubitz CC, Gallagher LA, Finley DJ, et al. Molecular analysis of minimally invasive follicular carcinomas by gene profiling. Surgery 2005;138:1042-1048.
27. Fryknas M, Wickenberg-Bolin U, Goransson H, et al. Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumour Biol 2006;27:211-220.
28. Pagedar NA, Chen DH, Wasman JK, et al. Molecular classification of thyroid nodules by cytology. Laryngoscope 2008;118:692-696. (Pubitemid 351496750)
29. Wiseman SM, Melck A, Masoudi H, et al. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis. Ann Surg Oncol 2008;15:2811-2826.
30. Griffith OL, Chiu CG, Gown AM, et al. Biomarker panel diagnosis of thyroid cancer: a critical review. Expert Rev Anticancer Ther 2008;8:1399-1413.
31. Cerutti JM, Latini FR, Nakabashi C, et al. Diagnosis of suspicious thyroid nodules using four protein biomarkers. Clin Cancer Res 2006;12:3311-3318.
32. Cerutti JM, Delcelo R, Amadei MJ, et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 2004;113:1234-1242. (Pubitemid 38544109)
33. DeLellis RA, Lloyd RV, Heitz PU, et al. (eds). WHO Classification of Tumors. Pathology and Genetics. Tumours of Endocrine Organs. IARC Press: Lyon, France, 2004.
34. DiVito KA, Charette LA, Rimm DL, et al. Long-term preservation of antigenicity on tissue microarrays. Lab Invest 2004;84:1071-1078. (Pubitemid 39025041)
35. Haataja L, Gurlo T, Huang CJ, et al. Many commercially available antibodies for detection of CHOP expression as a marker of endoplasmic reticulum stress fail specificity evaluation. Cell Biochem Biophys 2008; 51:105-107.
36. Matsumoto F, Fujii H, Abe M, et al. A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis. Hum Pathol 2006;37:1592-1600. (Pubitemid 44792227)
37. Patel MR, Stadler ME, Deal AM, et al. STT3A, C1orf24, TFF3: Putative Markers for Characterization of Follicular Thyroid Neoplasms From Fine-Needle Aspirates. Laryngoscope 2011;121:983-989.
38. Cerutti JM, Oler G, Delcelo R, et al. PVALB, a new Hurthle adenoma diagnostic marker identified through gene expression. J Clin Endocrinol Metab 2011;96: E151-E160.
39. Bryson PC, Shores CG, Hart C, et al. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Arch Otolaryngol Head Neck Surg 2008;134:581-586. (Pubitemid 351871015)
40. Netea-Maier RT, Hunsucker SW, Hoevenaars BM, et al. Discovery and validation of protein abundance differences between follicular thyroid neoplasms. Cancer Res 2008;68:1572-1580. (Pubitemid 351346867)
41. Hinsch N, Frank M, Doring C, et al. QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study. BMC Cancer 2009;9:93.
42. Griffith OL, Melck A, Jones SJ, et al. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol 2006;24:5043-5051. (Pubitemid 46631408)
43. Simon R, Radmacher MD, Dobbin K, et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003;95: 14-18. (Pubitemid 36124291)